Wenhu Xin

Dr. Wenhu Xin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
HZHongyu Zhang
Hongyu Zhang
CLChaoming Li
Chaoming Li
WLWenyan Li
Wenyan Li
WXWenhu Xin
Wenhu Xin
TQTian sheng Qin
Tian sheng Qin
Adenomyosis is a benign gynecological condition characterized by the proliferation of the endometrial stroma and glands into the myometrium, uterine volume enlargement, and peripheral smooth muscle hypertrophy. The typical clinical symptoms include chronic pelvic pain, abnormal uterine bleeding, and subfertility, all of which significantly impact quality of life. There are no effective prevention or treatment strategies for adenomyosis, partly due to a limited understanding of the pathological mechanisms underlying the initiation and progression of the disease. Given that signaling pathways play a crucial role in the development of adenomyosis, a better understanding of these signaling pathways is essential for identifying therapeutic targets and advancing drug development. The occurrence and progression of adenomyosis are closely linked to various underlying pathophysiological mechanisms, including proliferation, migration, invasion, fibrosis, angiogenesis, inflammation, oxidative stress, immune response, and epigenetic changes. This review summarizes the signaling pathways and targets associated with the pathogenesis of adenomyosis, including CXCL/CXCR, NLRP3, NF-κB, TGF-β/smad, VEGF, Hippo/YAP, PI3K/Akt/mTOR, JAK/STAT, and other relevant pathways. In addition, it identifies promising future targets for the development of adenomyosis treatment, such as m6A, GSK3β, sphks, etc.

27 November 2025 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
WXWenhu Xin
Wenhu Xin
KWKexin Wang
Kexin Wang
CTChengbin Tao
Chengbin Tao
XTXiuli Tian
Xiuli Tian
FWFang Wang
Fang Wang
Objective: This study investigated necroptosis-related molecular alterations in the endometrium of patients with polycystic ovary syndrome (PCOS) using quantitative proteomic analysis and developed a predictive model for pregnancy outcomes based on these findings. Methods: Liquid chromatography-tandem mass spectrometry was used to identify and quantify endometrial proteins. Differentially expressed proteins (DEPs) were screened and subjected to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses to identify key pathways. Candidate prognostic necroptosis–related proteins were obtained by intersecting DEPs with the necroptosis gene set, followed by univariate Cox and Least Absolute Shrinkage and Selection Operator (LASSO) regression analyses to select those associated with pregnancy outcomes and construct a predictive model. Results: A total of 611 DEPs were identified (132 upregulated and 479 downregulated). KEGG enrichment revealed significant involvement of the necroptosis pathway. Six necroptosis-related proteins were identified using Cox and LASSO regression analyses and used to construct the predictive model. Kaplan–Meier analysis showed that the low-risk group had significantly better pregnancy outcomes than the high-risk group. The model achieved an area under the receiver operating characteristic curve of 0.903 for predicting live birth at 37 weeks, and decision curve analysis demonstrated superior clinical benefit compared to conventional clinical indicators. Furthermore, correlation analysis revealed significant associations between necroptosis-related proteins and classical endometrial receptivity markers, suggesting potential molecular crosstalk. Conclusion: Proteomic profiling revealed enrichment of the necroptosis pathway in the endometrium of patients with PCOS. The constructed model indicated preliminary predictive potential for pregnancy outcomes, suggesting that necroptosis may contribute to impaired endometrial receptivity.

11 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
XXXu Xianyun
Xu Xianyun
WJWang Jiaxi
Wang Jiaxi
ZHZhang Hongyu
Zhang Hongyu
WYWang Yunyun
Wang Yunyun
GLGao Xue Lin
Gao Xue Lin
TQTian sheng Qin
Tian sheng Qin
Background and Objective: FOLR3 serves as an important member of the folate metabolic pathway and plays a crucial role in various malignant tumors. However, the expression pattern, diagnostic value, and regulatory mechanism of FOLR3 in endometrial cancer (EC) remain unclear. This study aimed to explore the expression characteristics, clinical significance, and related molecular regulatory networks of FOLR3 in EC through bioinformatics analysis. Methods: TCGA datasets served as training sets, while GSE17025 from GEO served as validation sets. FOLR3 differential expression was analyzed using Wilcoxon rank-sum test, diagnostic efficacy evaluated by ROC curves, and prognostic value assessed via Kaplan-Meier survival analysis. Candidate genes were identified through WGCNA, univariate Cox regression, and differential expression analysis. Key genes were screened using machine learning algorithms (RF, LASSO, SVM-RFE) and PPI network analysis. ceRNA regulatory networks were constructed, and immune infiltration was analyzed using CIBERSORT. Results: FOLR3 was significantly overexpressed in EC ( P < 0.01) with diagnostic AUC values > 0.6 in both datasets. High FOLR3 expression indicated poor prognosis (HR=2.5, P < 0.05). Among 5,539 differentially expressed genes, 3 key genes (AURKA, POLQ, CDKN2A) were identified via multi-algorithm screening. Enrichment analysis showed involvement in cell division, p53 signaling, and cellular senescence. The ceRNA network comprised 72 nodes and 169 relationships, with KCNQ1OT1 and XIST as key lncRNA regulators. FOLR3 positively correlated with memory B cells and M0 macrophages, negatively with naive B cells and resting mast cells, with significant immune score differences ( P < 0.05). Conclusion: FOLR3 was significantly upregulated in EC, serving as an effective diagnostic biomarker and independent prognostic predictor. FOLR3 participated in tumorigenesis via complex ceRNA networks and regulated the tumor immune microenvironment. This study provides novel molecular targets and theoretical foundation for precision diagnosis and therapy of EC.